BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12395173)

  • 1. [Severe adverse event following iv administration of 10 ml 6% Dextran60 (0.6 g) in a healthy volunteer].
    Lehmann G; Asskali F; Förster H
    Anaesthesist; 2002 Oct; 51(10):820-4. PubMed ID: 12395173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactoid reactions to plasma substitutes.
    Ring J
    Int Anesthesiol Clin; 1985; 23(3):67-95. PubMed ID: 2411667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, pathomechanism and prevention of dextran-induced anaphylactoid / anaphylactic reactions in man.
    Hedin H; Richter W; Messmer K; Renck H; Ljungström KG; Laubenthal H
    Dev Biol Stand; 1980; 48():179-89. PubMed ID: 6168503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The anaphylactoid reaction after colloid infusion].
    Ring J
    Fortschr Med; 1977 Nov; 95(41):2481-4. PubMed ID: 72035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
    Ring J; Seifert J; Struif E; Messmer K; Brendel W
    Chir Forum Exp Klin Forsch; 1977 Apr; ():31-5. PubMed ID: 87295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sideeffects of colloids (author's transl)].
    Messmer K; Ring J; Hedin H; Richter W; Seemann C
    Zentralbl Chir; 1978; 103(15):978-85. PubMed ID: 81575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
    Zinderman CE; Landow L; Wise RP
    J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and severity of anaphylactoid reactions to colloid volume substitutes.
    Ring J; Messmer K
    Lancet; 1977 Feb; 1(8009):466-9. PubMed ID: 65572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to dextran in Sweden 1970-1979.
    Ljungström KG; Renck H; Strandberg K; Hedin H; Richter W; Widerlöv E
    Acta Chir Scand; 1983; 149(3):253-62. PubMed ID: 6193664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].
    Allhoff T; Lenhart FP
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):301-6. PubMed ID: 7511449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dextran-induced anaphylactic shock during general anesthesia: a case report].
    Kawano H; Nomura K; Kawahito S; Ohshita N; Tanaka K; Oshita S
    Masui; 2012 Nov; 61(11):1265-8. PubMed ID: 23236936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational use of albumin and plasma substitutes.
    Thompson WL
    Johns Hopkins Med J; 1975 May; 136(5):220-5. PubMed ID: 47936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histamine liberation in man following plasma substitution with gelatine and dextran: cause of anaphylactic reactions in the hospital?].
    Thermann M; Doenicke A; Messmer K; Hamelmann H; Reiman J; Lorenz W
    Langenbecks Arch Chir; 1975; Suppl():435-7. PubMed ID: 54852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three fluid solutions for resuscitation in dengue shock syndrome.
    Wills BA; Nguyen MD; Ha TL; Dong TH; Tran TN; Le TT; Tran VD; Nguyen TH; Nguyen VC; Stepniewska K; White NJ; Farrar JJ
    N Engl J Med; 2005 Sep; 353(9):877-89. PubMed ID: 16135832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infusiontherapy with colloidal volumesubstitutes (author's transl)].
    Ring J; Messmer K
    Anaesthesist; 1977 Jun; 26(6):279-87. PubMed ID: 883609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man.
    Hedin H; Richter W
    Int Arch Allergy Appl Immunol; 1982; 68(2):122-6. PubMed ID: 6176555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infusions emergencies following the administration of plasma substitutes -- analysis of case reports to the committee on drugs. The problems of medical statistics, prophylaxis and immediate therapy (author's transl)].
    Ahnefeld FW; Fischer F; Frey R; Kilian J; Schöning B
    Anaesthesist; 1979 May; 28(5):207-20. PubMed ID: 380384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HES, dextran and gelatin--indications and tolerance].
    Laubenthal H; Sirtl C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. II. A comparison of the effects of 20 ml dextran 1, 15%, administered either admixed to or before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Rosberg B; Dhunér KG; Dahl S
    Acta Chir Scand; 1983; 149(4):349-53. PubMed ID: 6193666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective consideration of the incidence of anaphylactoid reactions following administration of Plasmasteril and Longasteril].
    Beez M; Dietl H
    Infusionsther Klin Ernahr; 1979; 6(1):23-6. PubMed ID: 84790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.